# OnCo record plasmablastic-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/plasmablastic-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "plasmablastic-lymphoma" ;
  schema:name "Plasmablastic lymphoma"@en ;
  schema:alternateName "PBL"@en, "Plasmablastic lymphoma of the oral cavity"@en, "Plasmablastic lymphoma, HIV-associated"@en ;
  schema:description "An aggressive lymphoma whose cells have taken on the appearance of plasma cells, so they no longer carry the CD20 marker that most B-cell lymphoma treatments aim at. It most often starts in the mouth or jaw, and about half of people diagnosed with it have HIV."@en ;
  schema:url <https://onco.cc/cancers/plasmablastic-lymphoma/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Plasmablastic_lymphoma> ;
  schema:citation <https://doi.org/10.1038/s41375-022-01620-2>, <https://doi.org/10.1182/blood.2022015851>, <https://doi.org/10.1016/j.clml.2023.12.014>, <https://doi.org/10.1002/ajh.25955>, <https://doi.org/10.1038/bjc.2015.94> ;
  onco:tag "heme", "lymphoma", "subtype-page" ;
  onco:related <https://onco.cc/cancers/hiv-associated-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/primary-effusion-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/fdg-pet/> ;
  onco:targets <https://onco.cc/pathways/myc/> ;
  onco:drugs <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/lenalidomide/> ;
  onco:terms <https://onco.cc/terms/ebv-term/>, <https://onco.cc/terms/lymphoma-b-versus-t-cell/>, <https://onco.cc/terms/lymphoma-classification-2022/>, <https://onco.cc/terms/lymphoma-nodal-versus-extranodal/> ;
  onco:standardOfCare <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/terms/ebv-term/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/pathways/myc/>, <https://onco.cc/cancers/hiv-associated-lymphoma/>, <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/terms/lymphoma-tx-regimen-alphabet/> .